Type 2 Biomarkers as Mediators of Clinical Remission With Biologics in Severe Asthma

  • Duong Duc Pham
  • , Hyouk Soo Kwon
  • , Woo Jung Song
  • , You Sook Cho
  • , Sei Won Lee
  • , Ga Young Ban
  • , Taehoon Lee
  • , So Young Park
  • , Young Hee Nam
  • , Byung Jae Lee
  • , Jin An
  • , Chan Sun Park
  • , Hyo In Rhyou
  • , Joo Hee Kim
  • , Hye Kyung Park
  • , Sang Ha Kim
  • , Min Suk Yang
  • , Min Hye Kim
  • , Kyung Min Ahn
  • , Ji Su Shim
  • Jeong Hee Choi, Sujeong Kim, Jae Woo Jung, Han Ki Park, Byung Keun Kim, Ji Hyang Lee, Young Chan Kim, Sang Min Lee, Sung Yoon Kang, Jae Woo Kwon, Gyu Young Hur, Ji Yong Moon, Kyoung Hee Sohn, Mi Ae Kim, Sae Hoon Kim, Sunyoung Yoon, An Soo Jang, Sang Hoon Kim, So Young Park, Hyun Jung Jin, So Ri Kim, Jae Hyun Lee, Pankaj K. Bhavsar, Ian M. Adcock, Dixey Piers, Nazanin Zounemat-Kermani, Yang Freda, Pujan H. Patel, Kian Fan Chung, Tae Bum Kim

Research output: Contribution to journalLetterpeer-review

Original languageEnglish
JournalAllergy: European Journal of Allergy and Clinical Immunology
DOIs
StateAccepted/In press - 2025

Keywords

  • T2-biomarker
  • mediation effect
  • remission
  • severe asthma

Cite this